Stress and multiple sclerosis (Journal of Neurology (2007) 254, (SUPPL. 2) (65-68) DOI: 10.1007/s00415-007-2015-4);Stress and multiple sclerosis

Journal of Neurology

Volumn 254, Issue 2 SUPPL., 2007, Pages 309-

  Mohr, David C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Depression; Health psychology; Multiple sclerosis; Psychoneuroimmunology; Stress

Indexed keywords

GADOLINIUM; GLUCOCORTICOID;

COPING BEHAVIOR; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISTRESS SYNDROME; HEALTH; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOCOMPETENT CELL; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOLOGY; PSYCHOPHYSIOLOGY; REVIEW; RISK FACTOR; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; STRESS;

ADAPTATION, PSYCHOLOGICAL; HUMANS; MULTIPLE SCLEROSIS; PERSONALITY; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL;

EID: 34248569767     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-008-0901-z     Document Type: Erratum

References (23)

1. Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362
2. Dantzer R (2001) Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 933:222-234
3. DeRijk RH, Eskandari F, Sternberg EM (2004) Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production. J Neuroimmunol 151:180-188
4. Gold SM, Mohr DC, Huitinga I, Flachenecker P, Sternberg EM, Heesen C (2005) The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol 26:644-652
5. Goodkin DE, Rooney WD, Sloan R, Bacchetti P, Gee L, Vermathen M, Waubant E, Abundo M, Majumdar S, Nelson S, Weiner MW (1998) A serial study of new MS lesions and the white matter from which they arise. Neurology 51:1689-1697
6. McEwen BS (1998) Protective and damaging effects of stress mediators. New England Journal of Medicine 338:171-179
7. Miller GE, Cohen S, Ritchey AK (2002) Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol 21:531-541
8. Mohr DC, Boudewyn AC, Genain CP (1999) Relationship between treatment for depression and interferon-gamma in patients with multiple sclerosis. Psychosom Med 61:112
9. Mohr DC, Goodkin DE, Bacchetti P, Boudewyn AC, Huang L, Marrietta P, Cheuk W, Dee B (2000) Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology 55:55-61
10. Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP (2001) Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Arch Neurol 58:1081-1086
11. Mohr DC, Goodkin DE, Nelson S, Cox D, Weiner M (2002) Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis. Psychosom Med 64:803-809
12. Mohr DC, Genain C (2004) Social support as a buffer in the relationship between treatment for depression and T-cell production of interferon gamma in patients with multiple sclerosis. J Psychosom Res 57:155-158
13. Mohr DC, Hart SL, Julian L, Cox D, Pelletier D (2004) Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 328:731
14. Mohr DC, Pelletier D (2006) A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Brain Behav Immun 20:27-36
15. Morale C, Brouwer J, Testa N, Tirolo C, Barden N, Dijkstra CD, Amor S, Marchetti B (2001) Stress, glucocorticoids and the susceptibility to develop autoimmune disorders of the central nervous system. Neurol Sci 22:159-162
16. Nisipeanu P, Korczyn AD (1993) Psychological stress as risk factor for exacerbations in multiple sclerosis. Neurology 43:1311-1312
17. Silver NC, Good CD, Barker GJ, MacManus DG, Thompson AJ, Moseley IF, McDonald WI, Miller DH (1997) Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Neurology 120:1149-1161
18. Then Bergh F, Kumpfel T, Trenkwalder C, Rupprecht R, Holsboer F (1999) Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology 53:772-777
19. Tortorella C, Codella M, Rocca MA, Gasperini C, Capra R, Bastianello S, Filippi M (1999) Disease activity in multiple sclerosis studied by weekly triple-dose magnetic resonance imaging. J Neurol 246:689-692
20. Uchino BN, Cacioppo JT, Kiecolt-Glaser JK (1996) The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health. Psychol Bull 119:488-531
21. van Winsen LM, Muris DF, Polman CH, Dijkstra CD, van den Berg TK, Uitdehaag BM (2005) Sensitivity to glucocorticoids is decreased in relapsing remitting multiple sclerosis. J Clin Endocrinol Metab 90:734-740
22. Warren S, Warren KG, Cockerill R (1991) Emotional stress and coping in multiple sclerosis (MS) exacerbations. J Psychosom Res 35:37-47
23. Wei T, Lightman SL (1997) The neuroendocrine axis in patients with multiple sclerosis. Brain 120(Pt 6):1067-1076